HDI Publications in association with NDRS
Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data
Gannon MR, Dodwell D, Miller K, Horgan K, Clements K, Medina J, et al.
Abstract
Background
Endocrine therapy ...
Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017
Zalin-Miller A, Jose S, Knott C, Paley L, Tataru D, Morement H, Toledano MB, Khan SA.
Abstract:
Background: ...
Variation in Rates of Post-Mastectomy Radiotherapy Among Women with Early Invasive Breast Cancer in England and Wales: A Population-Based Cohort Study.
Miller K, Gannon MR, Medina J, Clements K, Dodwell D, Horgan K, et al.
Abstract:
Aims
This study examined ...
Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018
Cook S, Pethick J, Kibbi N, Hollestein L, Lavelle K, de Vere Hunt I, Turnbull C, Rous B, Husain A, Burn J, ...
Long-term health outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer
Hend Hassan; Tameera Rahman; Andrew Bacon; Craig Knott; Isaac Allen; Catherine Huntley; Lucy Loong; Yvonne ...
Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996–2020
Lucy Loong, Catherine Huntley, Fiona McRonald, Francesco Santaniello, Joanna Pethick, Bethany Torr, Sophie Allen, ...
Second primary cancer risks for female and male breast cancer survivors
Isaac Allen; Tameera Rahman; Andrew Bacon; Craig Knott; Sophie Jose; Sally Vernon; Hend Hassan; Catherine Huntley; ...
Previously treated recurrent or advanced endometrial cancer in England: a real-world observational analysis
Heffernan K, Sen Nikitas FS, Shukla U, Camejo HS, Knott CS.
Abstract:
Objectives: In patients with ...
Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting
Knott CS, Heffernan K, Nikitas FS, Shukla U, Starkie-Camejo H. 812P
Abstract:
Background
Patients with ...
A registry study of relapsed or refractory multiple myeloma pre-exposed to 3 or more therapies including a proteasome inhibitor, an immunomodulatory agent and cd38-targeted monoclonal antibody therapy in England
Elsada A, Zalin-Miller A, Knott CS, Caravotas L.
Abstract:
Some patients with multiple myeloma are receiving ...
No results found.